Business
MedMira Ships 400,000 Tests to China and Receives Follow-on Order
Jul. 13, 2011 (Canada NewsWire Group) -- HALIFAX, July 13, 2011 /CNW/ - MedMira Inc., ("...
About this update from Medmira Inc.
[{"type":"text","content":"\n\n\n Jul. 13, 2011 (Canada NewsWire Group) -- \n\n#ReleaseContent TABLE\n{\n BORDER-COLLAPSE: collapse\n}\nTR.cnwUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 1px solid\n}\nTR.cnwDoubleUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 3px double\n}\nTR.cnwBoldUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 3px solid\n}\nTD.cnwUnderlinedCell\n{\n BORDER-BOTTOM: #000000 1px solid\n}\nTD.cnwDoubleUnderlinedCell\n{\n BORDER-BOTTOM: #000000 3px double\n}\nTD.cnwBoldUnderlinedCell\n{\n BORDER-BOTTOM: #000000 3px solid\n}\n#ReleaseContent TABLE.cnwBorderedTable TD\n{\n BORDER-RIGHT: black 1px solid;\n PADDING-RIGHT: 2px;\n BORDER-TOP: black 1px solid;\n PADDING-LEFT: 2px;\n PADDING-BOTTOM: 2px;\n BORDER-LEFT: black 1px solid;\n PADDING-TOP: 2px;\n BORDER-BOTTOM: black 1px solid;\n BORDER-COLLAPSE: collapse\n}\n#ReleaseContent TABLE TD\n{\n PADDING-RIGHT: 2px;\n PADDING-LEFT: 2px;\n PADDING-BOTTOM: 2px;\n PADDING-TOP: 2px\n}\n\n\nHALIFAX, July 13, 2011 /CNW/ - MedMira Inc., ("MedMira") (TSXV: MIR)\n (NASDAQ: MMIRF), a developer and marketer of rapid diagnostic\n technology and solutions, today announced that it has completed and\n shipped the order for 400,000 rapid HIV tests placed by its strategic\n partner in China, Triplex International Biosciences Co., Ltd.\n (Triplex), in April 2011.\n\n\n"The fulfillment of this initial order for Triplex went very smoothly,"\n said Hermes Chan, CEO, MedMira Inc.  "The Triplex sales strategy in the\n new China healthcare sector is working very well, with the number one\n ranking of our test in a  recent evaluation by the China National\n Center for Disease Control (China CDC) being a key marketing tool in\n many of their initiatives."\n\n\nTriplex has placed a follow-on order for MedMira rapid HIV tests as it\n continues to pursue sales opportunities in the outreach clinics and\n hospital laboratory vertical markets in the high growth rapid\n diagnostics market within China's restructured healthcare system.\n\n\n"We are very pleased with the sales progress our business development\n team is making with the MedMira rapid HIV test," said Yiu Ming Fung,\n President and Chairman of Triplex International Biosciences Co., Ltd.\n "The MedMira product has been a great addition to our product\n portfolio.  The test is achieving excellent results in ev...